This inventor holds 5 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Sumitomo Dainippon Pharma Co., Ltd., The Kitasato Institute, Sumitomo Pharma Co., Ltd.. Active years: 2017-2023.
Company Filing History:
4 out of 110 
2 out of 102 
1 out of 66 Years Active: 2017-2023
Title: Shingo Mizushima: Innovator in Medicinal Chemistry
Introduction
Shingo Mizushima is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have therapeutic applications. With a total of 5 patents to his name, Mizushima's work focuses on innovative solutions for bacterial infections and other diseases.
Latest Patents
Mizushima's latest patents include an oxo-substituted compound that exhibits an excellent β-lactamase inhibitory effect. This novel compound, represented by specific formulas, can be used either alone or in combination with β-lactam drugs to create effective preventive or therapeutic agents for bacterial infections. Additionally, he has developed a method for producing a benzimidazole derivative, which serves as a medicament and an intermediate for preparing other medicinal compounds.
Career Highlights
Throughout his career, Mizushima has worked with notable organizations such as Sumitomo Dainippon Pharma Co., Ltd. and The Kitasato Institute. His experience in these companies has allowed him to refine his expertise in drug development and medicinal chemistry.
Collaborations
Mizushima has collaborated with esteemed colleagues, including Toshio Kanai and Masafumi Komiya. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Shingo Mizushima's innovative work in medicinal chemistry has led to the creation of valuable compounds that address critical health challenges. His contributions continue to impact the field positively, showcasing the importance of research and development in medicine.